GOT YOUR BACK will be hosting an Open House at their retail location at 521 East Hector Street, Conshohocken, PA on December 12th from 1:00 p.m. - 4:00 p.m. Guests will include health and wellness professionals, chiropractors, massage therapists and those interested in alternative fitness and wellness throughout the tri-state area. Visitors will enjoy food, beverages, a free chair massage, and free on site diagnosis of the spine. This event is also open to the public and special discounts will be offered throughout the store exclusively for attendees of this event. [More]

A new study suggests that the inner sense of our cardiovascular state, our "interoceptive awareness" of the heart pounding, relies on two independent pathways, contrary to what had been asserted by prominent researchers. [More]

Researchers at the University of York have identified a part of the brain that responds to both facial and vocal expressions of emotion. [More]

Research and Markets(http://www.researchandmarkets.com/research/e7e6d1/european_mobility) has announced the addition of Frost & Sullivan's new report "European Mobility Aids Markets" to their offering. [More]

Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that Dysport® is now available in the United States for the treatment of cervical dystonia in adults. [More]

NovaDel Pharma Inc., has entered into a licensing agreement with privately-held Mist Acquisition, LLC to manufacture and commercialize the NitroMist® lingual spray version of nitroglycerine, a widely-prescribed and leading short-acting nitrate for the treatment of angina pectoris. [More]

Biospace med announced today that it continues to penetrate the U.S. market with its FDA-cleared ‘EOS’ x-ray imager—the world’s first ultra-low-dose x-ray technology—recently adding new customers in the Midwest and Southeast regions of the United States. In addition, Professor Georges Charpak, inventor of the EOS technology, has received the ‘Centenary Medal’ from the French Radiological Society (SFR), the esteemed organization’s highest honor. [More]

Health Discovery Corporation is pleased to announce numerous additional issued patents and Notices of Allowance since its last press release describing its intellectual property portfolio. The Company now has a total of 37 issued patents, 4 Notices of Allowance and 30 pending patent applications. [More]

The Foundation for Chiropractic Progress (www.f4cp.com), a not-for-profit organization dedicated to increasing public awareness of the benefits of chiropractic, joins the 92 national associations that are currently members of the World Federation of Chiropractic in support of World Spine Day taking place on October 16, 2009. [More]

Straighten Up Alberta, a free, public service program launched today by Alberta's chiropractors, is a quick, simple stretching program aimed at helping Albertans' improve their posture and spinal health in just three minutes a day. [More]

More than half of the House's Democrats Tuesday signed a letter expressing opposition to a key element of the Senate Finance Committee's health overhaul -- the proposal to tax expensive health insurance plans. [More]

Henry Ford West Bloomfield Hospital is embarking on a research study for advanced Parkinson's disease using a state-of-the-art treatment called gene transfer. [More]

PortSys UK, a wholly owned subsidiary of Portcullis Systems, Inc. a US-based company and a Microsoft™ and HP™ partner offering solutions for secure remote access, announced today that Fareham College, a Further Education College offering a wide range of full and part time vocational and academic courses in South Hampshire, has chosen Portsys UK’s Secure Application Access Gateway appliance to bring remote access options to the college. [More]

Memphis-based neurologist Moacir Schnapp, M.D., creator of the iPosture, today announced the launch of his posture improvement device for golfers – the iPosture Golf-Pro. [More]

MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has initiated a Phase I study at the University of Pittsburgh Medical Center with atropine sulfate delivered from the MicroDose proprietary dry powder inhaler (DPI). The study is a further step in the development program for an atropine inhaler to treat nerve agent poisoning in military and civil defense applications. [More]